Page results
-
A lung cancer patient at UCLH is the first to receive a novel cancer vaccine designed to prime the immune system to recognise and fight cancer cells.
-
UCLH has received excellent results in the 2023 National Adult Inpatient Survey this year, with patients rating their overall care 8.8 out of 10. This is an improvement on last year's score of 8.7 and once again makes us the best performing acute/combined trust in England.
-
UCLH is making a commitment to reduce its impact on the environment with a 10-point plan to reach net zero carbon dioxide emissions in 10 years.
-
We provide routine histopathological diagnoses using both standard techniques and advanced diagnostics including immunocytochemistry, fluoresent in-situ hybridisation (FISH), and polymerase chain…
-
This page offers ways you can help us to prevent infection and make your babies safer.
-
Overall, most women (over 90%) spontaneously give birth to their baby after 37 weeks of pregnancy, called term delivery. Approximately 10%, or 1 in 10 women spontaneously give birth to their baby…
-
UCLH is one of only twelve specialist centres in the UK for the treatment of penile cancer, and one of only two in London. UCLH provides a comprehensive penile cancer service for patients, together…
File results
-
FOI/2023/0614 - Communications
-
FOI/2023/0750 - Treatment for non-small cell lung cancer
-
FOI/2023/0246 - Digital services used for patient care
-
FOI/2023/0452 - Eating disorders
-
FOI/2023/0453 - Patient transport home bookings
-
FOI/2023/0455 - NHS remediating elective surgery operations
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2023/0458 - Patient trolleys
-
FOI/2023/0459 - Multiple myeloma treatment
-
FOI/2023/0461 - UCLH operating system software/ data centres hybrid cloud